Today: 5 March 2026
Subscribe
Browse Category

Earnings Reports 6 November 2025

Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining (HL) Soars on Record Q3 2025: $409.5M Revenue, $0.15 EPS, Dividend Declared — What to Know Today (Nov 6, 2025)

Hecla Mining reported record Q3 revenue of $409.5 million and net income of $100.6 million, beating analyst estimates. The company tightened 2025 production guidance, announced new permitting wins, and declared dividends on both common and preferred shares. Shares surged over 10% intraday. Hecla fully repaid its revolving credit facility and ended the quarter with $133.9 million in cash.
6 November 2025
···
B2Gold (BTG) Q3 2025: Goose Mine Hits Commercial Production, Dividend Declared, Guidance Reiterated — Nov 6, 2025

B2Gold (BTG) Q3 2025: Goose Mine Hits Commercial Production, Dividend Declared, Guidance Reiterated — Nov 6, 2025

B2Gold reported Q3 gold revenue of $782.9 million and adjusted EPS of $0.14, with total production at 254,369 ounces. The Goose Mine in Nunavut reached commercial production on October 2, prompting a cut in 2025 output guidance to 50,000–80,000 ounces. Fekola Complex in Mali continues normal operations with 2025 guidance unchanged. A Q4 dividend of $0.02 per share was declared, payable December 15.
6 November 2025
···
Intel (INTC) Today — Nov 6, 2025: Quarterly 10‑Q Details U.S. Government Stake, Nvidia $5B Share Sale Terms, and Foundry Progress as Shares Slip

Intel (INTC) Today — Nov 6, 2025: Quarterly 10‑Q Details U.S. Government Stake, Nvidia $5B Share Sale Terms, and Foundry Progress as Shares Slip

Intel’s Q3 10-Q, filed Nov. 6, confirms the U.S. government now owns about 5.8% of Intel after receiving 275 million shares, with additional shares in escrow and warrants tied to its foundry business. Intel also closed a $2 billion private placement to SoftBank and agreed to a $5 billion placement to Nvidia. The company reported a $5.55 billion gain from deconsolidating Altera. INTC shares traded slightly lower after the filing.
6 November 2025
·
Fastly (FSLY) Soars After Record Q3: Security Revenue +30%, Guidance Raised; Shares Jump ~26% on Nov. 6, 2025

Fastly (FSLY) Soars After Record Q3: Security Revenue +30%, Guidance Raised; Shares Jump ~26% on Nov. 6, 2025

Fastly shares surged 26% intraday after reporting record Q3 revenue of $158.2 million, up 15% year over year, and raising guidance for Q4 and FY2025. Security revenue jumped 30% to $34 million, now 21% of total sales. Non-GAAP gross margin reached 62.8%, and free cash flow turned positive at $18.1 million. RBC and Piper Sandler raised price targets, citing improved fundamentals.
6 November 2025
···
Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

Salesforce shares dropped about 6% Thursday, among the steepest declines in the Dow, as software stocks broadly retreated. Analysts’ 12-month price targets range from $221 to $430, with consensus near $325 and most ratings at “Buy.” Options trading this week showed mixed sentiment and high volatility. Salesforce reports Q3 FY26 results after the bell on Dec. 3.
6 November 2025
···
Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins reported Q3 revenue of $8.32 billion and adjusted EPS of $5.59, both above estimates, driven by strong data-center power demand. The company raised its quarterly dividend to $2.00 and launched a strategic review of its Accelera electrolyzer business after $240 million in non-cash charges. Shares rose 7.6% by midafternoon. No 2025 outlook was issued.
6 November 2025
···
Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme reported Q3 2025 revenue of $375.3 million, down 1.2% year over year, but posted a surprise adjusted EPS of $0.01, beating expectations for a loss. Shares jumped as the company reiterated guidance for stronger cash flow into year-end. Net loss was $20.1 million, or –$0.11 per share GAAP. Global points of access fell 6.1% after closing underperforming locations.
6 November 2025
··
Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra reported Q3 GAAP net income of $652 million and revenue of $4.97 billion, down 21% year over year. The board approved an extra $1 billion in share repurchases through 2027. The company completed 2.6 GW in gas plant acquisitions and signed a 20-year, 1,200-MW nuclear PPA. 2025 Adjusted EBITDA guidance narrowed to $5.7–$5.9 billion; 2026 guidance set at $6.8–$7.6 billion.
6 November 2025
··
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics reported Q3 2025 revenue of $67.5 million, up 13% sequentially but below analyst expectations, and a net loss of $91.3 million, or $0.25 per share. Gross margin rose to 43%. Management reaffirmed full-year revenue guidance of $250–$300 million. Over 80 U.S. treatment centers are now active, and cash reserves totaled $307 million at quarter’s end.
6 November 2025
···
Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax raised its FY2025 adjusted revenue outlook to $1.04–$1.06 billion after reporting Q3 revenue of $70 million, above estimates. The company posted a GAAP net loss of $202 million for the quarter, impacted by $126 million in non-cash charges tied to Maryland site consolidation and debt. Two $25 million milestone payments from Sanofi will be recognized in Q4. Cash stood at $778 million as of September 30.
6 November 2025
·····
Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Fortinet reported Q3 revenue of $1.72 billion and adjusted EPS of $0.74, both up 14% year-over-year and ahead of estimates. Shares fell after the company issued Q4 guidance below expectations, projecting revenue of $1.825–$1.885 billion and EPS of $0.73–$0.75. Several analysts cut price targets but maintained neutral ratings. Multiple law firms issued class-action reminders tied to alleged firewall cycle misstatements.
6 November 2025
···
DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash shares fell about 9% premarket after the company said it will boost 2026 spending by several hundred million dollars to accelerate a new global tech platform, overshadowing strong Q3 results. Revenue rose 27% to $3.45 billion and total orders climbed 21%, but EPS of $0.55 missed estimates. The Deliveroo acquisition closed Oct. 2. DoorDash’s $5 billion buyback remains unused.
6 November 2025
··
D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum posted Q3 revenue of $3.7 million, doubling year over year, with bookings jumping to $2.4 million. The company ended the quarter with a record $836.2 million in cash, boosted by warrant exercises, while GAAP net loss widened to $140 million due to $121.9 million in non-cash charges. Shares traded near $31 intraday. Over $12 million in additional bookings closed after quarter-end.
6 November 2025
···
Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm reported fiscal Q2 revenue of $1.14 billion, up 34% year-over-year and above estimates, with non-GAAP EPS of $0.39. The company raised Q3 revenue guidance to about $1.225 billion, citing strong AI demand. Royalties climbed 21% to $620 million, licensing jumped 56% to $515 million. Major brokers raised price targets after results.
6 November 2025
····
e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty shares plunged over 20% after the company forecast FY‑2026 revenue of $1.55–$1.57 billion and adjusted EPS of $2.80–$2.85, both missing analyst estimates. Tariff costs exceeding $50 million and 75% China sourcing pressured margins, which fell 165 basis points. Q2 net sales rose 14% to $343.9 million; adjusted EPS was $0.68. Piper Sandler and UBS downgraded the stock following the guidance.
6 November 2025
··
Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

Comstock Resources (CRK) Jumps as Q3 Results, $430M Divestiture and Rising RS Rating Put Haynesville Gas in Focus — Nov. 6, 2025

Comstock Resources shares rose 5.5% to $21.14 midday after reporting Q3 revenue of $449.9 million and adjusted EPS of $0.09, citing higher gas prices and lower costs. The company advanced a $430 million Shelby Trough asset sale, expected to close in December 2025. Three new Western Haynesville wells averaged initial production of 32 MMcf/d. Liquidity stood at $939.2 million as of September 30.
6 November 2025
···
Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health (OSCR) Q3 2025: ~$3.0B Revenue, EPS Beats, 2025 Guidance Reaffirmed; Balance Sheet Simplified via Note Exchange — Nov. 6, 2025

Oscar Health reported Q3 revenue of $2.99 billion, up 23% year-over-year but below analyst estimates. The company posted a net loss of $137.5 million, or –$0.53 per share, beating EPS expectations. Medical loss ratio rose to 88.5%. Oscar exchanged $187.5 million of 2031 notes for about 23.3 million shares and reaffirmed its 2025 outlook.
6 November 2025
··
1 … 209 210 211 212 213 … 226
Go toTop